PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: PillJogger, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PillJogger, Inc. Presents New Approach to Medication Adherence - Non-adherence to health prescriptions is a $300 billion problem in the United States. PillJogger plans to solve this problem with an engaging mobile solution designed to use rewards and positive reinforcement - PillJogger.com
PillJogger, Inc. Presents New Approach to Medication Adherence

 

NewswireToday - /newswire/ - San Francisco, CA, United States, 2012/05/10 - Non-adherence to health prescriptions is a $300 billion problem in the United States. PillJogger plans to solve this problem with an engaging mobile solution designed to use rewards and positive reinforcement - PillJogger.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

PillJogger, Inc., a Silicon Valley start-up, has developed a unique approach to the $300 billion problem of medication non-adherence (not taking your prescribed medicine). The smartphone and tablet-based solution fosters user engagement with a platform that focuses on “human factors,” according to CEO Robert Pakter, M.D. “If it isn’t fun and rewarding, users aren’t going to come back,” said Dr. Pakter.

PillJogger, Inc. (pilljogger.com) was founded on two principles. First, traditional approaches to medical compliance haven’t worked. Second, the convergence of smart-mobile technology with federally mandated e-prescribing offered a solution without precedent. In fact, this solution benefitted every stakeholder, including patient, provider, pharmaceutical manufacturer, retail pharmacy, and payer.

With PillJogger, users are rewarded with rich content as well as economic incentives for participating on the platform. Furthermore, the platform becomes more individualized with greater user interaction. And the more adherent the user is, the greater the rewards.

The PillJogger team of doctors, pharmacy insiders, programmers, mobile technology experts and scientists are working hard to help improve health and save lives. “We’re proud of what we’ve built and more so, of what’s in development,” Dr. Pakter said of his team. “And I’m happy to say we’re working to provide solutions for some of the most established players in pharma and related businesses,” he added.

The PillJogger Lite application- (non-sponsored) is free on the iTunes app store now.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PillJogger, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


PillJogger, Inc. Presents New Approach to Medication Adherence

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Amy Romanek - PillJogger.com 
415-689-5869 news[.]pilljogger.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PillJogger, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PillJogger, Inc. / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Persistence Market Research Publishes Microtome Cryostat Equipment Market Opportunities and Forecasts, 2017-2025
North America to Account for 4.3% CAGR in Global Hip Replacement Market Reports Persistence Market Research
HPMC Capsules Market to Register 10.9% CAGR During 2017-2025 Finds Persistence Market Research
Persistence Market Research Publishes Blood Thinner Market Opportunities and Forecasts 2017-2025
Occupational Medicine Market Estimated to Expand At A Robust CAGR Over 2025 Notes PMR
Persistence Market Research Publishes Traditional Chinese Medicine Market Forecast Over 2017-2025
Inferior Vena Cava Filters Market to Register A Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Disposable Diabetes Devices Market Expected to Generate Huge Profits by 2025 Finds Reports Persistence Market Research
Cardiac Biomarkers Market Expected to Generate Huge Profits by 2017-2025 Reports PMR
Stone Management System Market Foreseen to Grow Exponentially Over 2017-2025 Finds PMR
Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit RightITnow Ltd

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)